ATLANTA, GA – – (Globe Newswire – September 11, 2023) – – Holzer & Holzer, LLC informs investors that a class action lawsuit has been filed against Tandem Diabetes Care, Inc. (“Tandem” or “the Company”) (NASDAQ: TNDM). The lawsuit alleges Tandem provided the public with material information regarding projected revenue and sales for the year ending 2022 that created “a materially flawed impression of the Company’s sales and revenue position.”

If you bought shares of Tandem between August 3, 2022 and November 2, 2022, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at jkarr@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/tandem/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is November 7, 2023.